RetractedArticleOncoTargets and therapy2017

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer.

Xuelu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.